Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.
Blood. 2024 Jan 25;143(4):336-341. doi: 10.1182/blood.2023021579.
Blood. 2024.
PMID: 37647641
A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients.
HaemSTAR Collaborators.
HaemSTAR Collaborators.
Br J Haematol. 2022 Jan;196(2):433-437. doi: 10.1111/bjh.17692. Epub 2021 Dec 3.
Br J Haematol. 2022.
PMID: 34859421
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.